A case of peritoneal serous papillary carcinoma

Japanese Journal of Cancer and Chemotherapy

Volumn 38, Issue 8, 2011, Pages 1337-1340

  Takeuchi, Nobuhiro ^a   Sakata, Yoshio ^a   Nishida, Yu ^a   Nomura, Yusuke ^a   Makino, Tetsuya ^a   Maeda, Tetsuo ^a   Tada, Hidetoshi ^a   Kimoto, Takeo ^a   Ueno, Sayaka ^b   Fujiwara, Kiyoshi ^b  

^a Kawasaki Hospital   (Japan)

^b HYOGO CANCER CENTER   (Japan)

Author keywords

Paclitaxel and carboplatin; Peritoneal serous papillary carcinoma; Second look operation

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ABDOMINAL DISTENSION; AGED; ARTICLE; ASCITES; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLARY CARCINOMA; PERITONEAL BIOPSY; PERITONEUM SEROUS PAPILLARY CARCINOMA; SECOND LOOK SURGERY; TREATMENT OUTCOME;

EID: 80054732640     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Swerdlow M: Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report. Am J Obstet Gynecol 77(1): 197-200, 1959.
2. Feuer GA, Shevchuk M and Calanog A: Normal-sized ovary carcinoma syndrome. Obstet Gynecol 73(5 Pt 1): 786-792, 1989.
3. Bloss JD, Liao SY, Buller RE, et al.: Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50(3): 347-351, 1993.
4. August CZ, Murad TM and Newton M: Multiple focal extraovarian serous carcinoma. Int J Gynecol Pathol 4(1): 11-23, 1985.
5. Levanon K, Crum C and Drapkin R: New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 26(32): 5284-5293, 2008.
6. Piek JM, Kenemans P and Verheijen RH: Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol 191(3): 718-732, 2004.
7. Gooneratne S, Sassone M, Blaustein A, et al.: Serous surface papillary carcinoma of the ovary: a clinicopathologic study of 16 cases. Int J Gynecol Pathol 1(3): 258-269, 1982.
8. Kindelberger DW, Lee Y, Miron A, et al.: Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 31(2): 161-169, 2007.
9. Sheibani K, Shin SS, Kezirian J, et al.: Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 15(8): 779-784, 1991.
10. Strnad CM, Grosh WW, Baxter J, et al.: Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma. Ann Intern Med 111(3): 213-217, 1989.
11. Schorge JO, Miller YB, Qi LJ, et al.: Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol 76(3): 369-372, 2000.
12. Piver MS, Eltabbakh GH, Hempling RE, et al.: Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol 67(2): 141-146, 1997.